Press release Oncology Venture & Alpha Blue Ocean mutually terminates agreement with EHGO as part of final financing

NEXT STORY
ASLAN Pharmaceuticals to Present at 9th Annual SVB Leerink Global Healthcare Conference
PREV STORY
Novartis announces FDA and EMA filing acceptance of ofatumumab, a novel B-cell therapy for patients with relapsing forms of multiple sclerosis (RMS)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Telepresence Robot Market 2018-2023 by Component (Head and Body) & Application (Education, Healthcare, Enterprise, and Homecare)

Dublin, Nov. 05, 2018 (GLOBE NEWSWIRE) -- The "Telepresence Robot Market by Component (Head ...

author_avatar
NASDAQ Market News

Athenex to Provide a Corporate and Financial Update for the Fourth Quarter and Full Year 2020 on March 1, 2021

author_avatar
NASDAQ Market News

Galecto Appoints Industry Leader Bertil Lindmark, MD, PhD, as Chief Medical Officer

author_avatar
NASDAQ Market News